Active Research Protocols
- 02-AR-0272 – A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus
- 03-DK-0071 – Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy
- 92-DK-0156 – Studies of Immunologically-Mediated Kidney Diseases
- 94-AR-0066 – Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014